|
rdf:type |
|
|
lifeskim:mentions |
|
|
pubmed:issue |
9582
|
|
pubmed:dateCreated |
2007-7-16
|
|
pubmed:databankReference |
|
|
pubmed:abstractText |
The optimum use of cytotoxic drugs for advanced colorectal cancer has not been defined. Our aim was to investigate whether combination treatment is better than sequential administration of the same drugs in patients with advanced colorectal cancer.
|
|
pubmed:commentsCorrections |
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
AIM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Jul
|
|
pubmed:issn |
1474-547X
|
|
pubmed:author |
pubmed-author:AntoniniNinja FNF,
pubmed-author:CreemersGeert-Jan MGJ,
pubmed-author:DalesioOtiliaO,
pubmed-author:DoumaJoepJ,
pubmed-author:ErdkampFrans L GFL,
pubmed-author:HonkoopAafke HAH,
pubmed-author:KoopmanMiriamM,
pubmed-author:LoosveldOlaf J LOJ,
pubmed-author:MolLindaL,
pubmed-author:PuntCornelis J ACJ,
pubmed-author:RodenburgCees JCJ,
pubmed-author:SinnigeHarm A MHA,
pubmed-author:SleePeter H Th JPH,
pubmed-author:TesselaarMargot E TME,
pubmed-author:VreugdenhilGerardG,
pubmed-author:WalsJaapJ,
pubmed-author:WerterMarjon J B PMJ,
pubmed-author:de JongRobert SRS,
pubmed-author:van BochoveAartA
|
|
pubmed:issnType |
Electronic
|
|
pubmed:day |
14
|
|
pubmed:volume |
370
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
135-42
|
|
pubmed:meshHeading |
pubmed-meshheading:17630036-Adult,
pubmed-meshheading:17630036-Aged,
pubmed-meshheading:17630036-Aged, 80 and over,
pubmed-meshheading:17630036-Antineoplastic Combined Chemotherapy Protocols,
pubmed-meshheading:17630036-Camptothecin,
pubmed-meshheading:17630036-Colorectal Neoplasms,
pubmed-meshheading:17630036-Deoxycytidine,
pubmed-meshheading:17630036-Female,
pubmed-meshheading:17630036-Fluorouracil,
pubmed-meshheading:17630036-Humans,
pubmed-meshheading:17630036-Male,
pubmed-meshheading:17630036-Middle Aged,
pubmed-meshheading:17630036-Organoplatinum Compounds,
pubmed-meshheading:17630036-Survival Rate
|
|
pubmed:year |
2007
|
|
pubmed:articleTitle |
Sequential versus combination chemotherapy with capecitabine, irinotecan, and oxaliplatin in advanced colorectal cancer (CAIRO): a phase III randomised controlled trial.
|
|
pubmed:affiliation |
Radboud University Nijmegen Medical Centre, Nijmegen, Netherlands.
|
|
pubmed:publicationType |
Journal Article,
Randomized Controlled Trial,
Research Support, Non-U.S. Gov't,
Multicenter Study,
Clinical Trial, Phase III
|
